Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients

Cancer

Volumn 88, Issue 5, 2000, Pages 1025-1029

  Saeki, Ayuko ^a   Tamura, Shinji ^a   Nobuyuki, Ito ^a   Kiso, Shinichi ^a   Matsuda, Yasuo ^b   Yabuuchi, Iwao ^b   Kawata, Sumio ^a,c   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Otemae Hospital   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BAX; Hepatocellular carcinoma; hMSH3; hMSH6; M6P IGFIIR; Microsatellite instability; Slippage related frameshift mutation; TGF RII

Indexed keywords

AMINO ACID; PROTEIN BAX; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN TISSUE; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MICROSATELLITE INSTABILITY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; FEMALE; FRAMESHIFT MUTATION; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, IGF TYPE 2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034162468     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1025::AID-CNCR11>3.0.CO;2-U     Document Type: Article

References (41)

1. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-63.
2. Drummond JT, Li GM, Longley MJ, Modrich P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995;268:1909-12.
3. Polombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995;268: 1912-4.
4. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, et al. Mutations of GTBP in genetically unstable cells. Science 1995;268:1915-7.
5. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
6. Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y, et al. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993;53:5087-9.
7. Risinger JI, Berchuck A, Kohler MF, Watoson P, Lynch HT, Boyd J. Genetic instability of microsatellite in endometrial carcinoma. Cancer Res 1993;53:5100-3.
8. Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, et al. Instability of short tandem repeats in human cancers. Nat Genet 1994;6:152-6.
9. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.
10. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
11. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
12. Chung YJ, Song JM, Lee JY, Jung YT, Seo EJ, Choi SW, et al. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinoma in a high-risk population. Cancer Res 1996;56: 4662-5.
13. Souza RF, Appel R, Yin J, Wang S, Somolinski KN, Abaham JM, et al. Microsatellite instability in the insulinlike growth factor II receptor gene in gastrointestinal tumors. Nat Genet 1996;14:488.
14. Rampino N, Yamamoto H, lonov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
15. Abe T, Ouyang H, Migita T, Kato Y, Kimura M, Shiba K, et al. The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability. Eur J Surg Oncol 1996;22:474-7.
16. Yin J, Kong D, Wang S, Zou TT, Souza RF, Smolinski KN, et al. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat 1997;10:474-8.
17. Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1997;57:4420-6.
18. Ottini R, Falchetti M, D'Amico C, Saieva C, Masula G, Frati L, et al. Mutations at coding mononucleotide repeats in gastric cancer with the microsatellite mutator phenotype. Oncogene 1998;16:2767-72.
19. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80: 827-41.
20. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982; 2:215.
21. Sherlock S, Fox FA, Niazi SP, Scheuer PJ. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet 1970;i:1243.
22. Nakanishi K, Watanabe J, Furuta S, et al. High prevalence of antibody to the hepatitis C virus patients with hepatocellular carcinoma in Japan. Cancer Res 1991;67:429.
23. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG, et al. Aetiological aspects of primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria: an epidemiological investigation. Br J Cancer 1984;50:389.
24. Enwonwu CO. The role of dietary aflatoxin in the genes of hepatocellular carcinoma in developing countries. Lancet 1984;ii:956.
25. Yamada T, Angus T, Souza D, Finkelstein S, Jirtle R. Loss of the gene encoding mannose 6-phosphate/insulinlike growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A 1997;94:10351-5.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
27. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations. Nature 1996;382:499-500.
28. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749-56.
29. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992; 68:775-85.
30. Moustakas A, Lin HY, Henis YI, Plamondon J, O'Connor-McCourt MD, Lodish HF. The transforming growth factor beta receptors type I, II and III form hetero-oligomeric complexes in the presence of ligand. J Biol Chem 1993;268:22215-8.
31. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-14.
32. Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 1989;264:12115-8.
33. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulinlike growth factor II receptor. Proc Natl Acad Sci U S A 1991;88:580-4.
34. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor type II receptors. Annu Rev Biochem 1992;61:307-30.
35. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9.
36. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
37. Prolla TA, Abuin A, Bradley A. DNA mismatch repair deficient mice in cancer research. Semin Cancer Biol 1996;7: 241-7.
38. Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nat Med 1996;2:630-1.
39. Wada I, Kanada H, Nomura K, Kato Y, Machinami R, Kitagawa T. Failure to detect genetic alteration of the mannose-6-phosphate/insulinlike growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinoma in Japan. Hepatology 1999;29:1718-21.
40. Salvucci M, Lemoine A, Azoulay D, Sebagh M, Bismuth H, Reynes M, et al. Frequent microsatellite instability in post hepatitis B viral cirrhosis. Oncogene 1996;13:2681-5.
41. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 1998;45:1206-13.